Answers are grounded in this paper and cite their sources.
This paper studies two structural theorems for the defect factor Dr(G) =∥H1(Fr,G)∥/∥G∥r−1 of finite groups. The first is the spectral Gustafson theorem: for every nonabelian finite group G and every integer r ≥ 1, Dr(G) ≤(2r +3)∥G∥/(4·2r); the case r = 1 is the conjugacy-class-count form of Gustafson’stheorem, and r ≥ 2 yields the sharp bound for the entire spectral family on the defect side; equality holds if and only if ∥G : Z(G)∥ = 4. Such groups are completelyparametrized by standard building blocks (A,τ,[w]), the building blocks being inbijection with isomorphism classes of “an equality group together with an index2 abelian subgroup”, and every equality group has exactly three such subgroups.The second is the η channel decomposition: writing cη = ∑︁ χ⟨χ ⊗ ¯χ,η⟩, one has∥H1(F2,G)∥ = ∑︁ ηc2 η; the genus decomposition exhibits the Cauchy–Schwarz lowerbound as the contribution of the principal channel and yields a new lower boundparametrized by the number t of nonprincipal participating channels; iterating thesame Parseval mechanism over the whole spectral family gives the higher channel∑︁ identity ∥H1(Fr,G)∥ = ∑︁ η cη · c(r) η and its corollary, the degree-weighted identityη η(1)cη = ∥G∥. Machine checks close on about seven hundred nonabelian groupconstructions: zero violations of the spectral bound, zero inconsistencies in theequality characterization, bitwise verification of the character tables of five groups,and bitwise agreement of the higher channel identity at the r = 3 section. Threenegative assets close off the three overstrong statements “the raw spectrum is anisoclinism invariant”, “the constant can be improved”, and “the spectrum is a complete classification invariant”.
No takes yet. Share an insight, caveat, or question.
zhou et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: